New treatment options for fibromyalgia: critical appraisal of duloxetine.

Neuropsychiatr Dis Treat · 2008 · PMC2526374 · PMID 18830399

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

failed to reach significancep = 0.06so close (0.05 < p ≤ 0.1)

A reduction of at least 50% in the FIQ pain score was achieved in 27.7% of the duloxetine group and in 16.7% of the placebo group, but this difference failed to reach significance (p = 0.06).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.